Fundz
You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →

Israeli medtech FIZE Medical raises $20M Series B co-led by Asahi Kasei Medical and Rapha Capital to advance AI-guided ICU care.

PRIVATESep 17, 2026•about 4 hours ago

Amount Raised

$20 Million

Round Type

Series B

Tel AvivBiotechnologyHealth CareMedical

Investors

Rapha Capital ManagementAsahi Kasei Medical

Description

FIZE Medical announced the first close of a $20 million Series B financing round co-led by Asahi Kasei Medical and Rapha Capital Management. The funding will accelerate development of FIZE Optima, an AI-driven platform for predicting fluid-related risks in ICU patients. FIZE has developed a system for monitoring kidney function and managing fluid balance in critically ill patients. The financing expands FIZE's strategic relationship with Asahi Kasei Medical, which will now distribute its products in Europe in addition to serving as its exclusive distributor in Japan.

Company Information

Company

FIZE Medical

Location

Tel Aviv, Tel Aviv District, Israel

About

FIZE Medical is a company developing fluid management systems for critically ill patients. Founded in 2011, it focuses on technology designed for intensive care, addressing hemodynamic status management. The company has raised a total of $29 million from various investors. It currently has about 40 employees operating in both Israel and the U.S.

Don't miss FIZE Medical's next move

Get an email the moment FIZE Medical raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

4 contacts
Predictive Intelligence
Strategic

ML-powered predictions for FIZE Medical's next move

See what Strategic adds

Funding Insights

Based on industry data
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

FIZE Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.